Related Experiment Video
Updated: Jun 16, 2026
03:59
Therapeutic Massage for Psychological Well-being in Geriatric Oncology
Published on: May 22, 2026
[Geriatric evaluation in oncology in the elderly subject]
1Groupement de la Gériatrie des Hospices Civils de Lyon, UPCOG de Lyon: Programme Lyonnais d'Oncogériatrie (PROLOG), Hôpital gériatrique Antoine Charial, 40, Avenue de la Table de Pierre, 69340 Francheville, France. gilles.albrand@chu-lyon.fr
Summary
Geriatric evaluations are crucial for older cancer patients due to population heterogeneity. A Detailed Geriatric Evaluation (DGE) helps create individualized care plans by assessing comprehensive health issues and functional impacts.
Area of Science:
- Geriatric oncology
- Clinical geriatrics
- Patient-centered care
Context:
- Elderly cancer patients present unique challenges due to population heterogeneity.
- Standard oncological treatments validated on younger populations may not be suitable for the elderly.
- National Comprehensive Cancer Network (NCCN) and International Society of Geriatric Oncology (SIOG) guidelines recommend geriatric assessments.
Purpose:
- To highlight the complexity of oncological management in the heterogeneous elderly population.
- To emphasize the importance of geriatric evaluations before initiating cancer treatment.
- To detail the components and objectives of a Detailed Geriatric Evaluation (DGE).
Summary:
- Geriatric assessment encompasses Multidimensional Geriatric Evaluation (MGE) and Detailed Geriatric Evaluation (DGE).
- DGE is a five-phase medical process to comprehensively assess an elderly patient's health.
- It involves identifying problems, differentiating aging effects from pathology, assessing functional and social impacts, and prioritizing health issues.
Impact:
- Facilitates the development of individualized oncological care programs for elderly patients.
- Improves the adherence to and efficacy of treatment recommendations by considering the patient's overall situation.
- Enhances the quality of care and outcomes for geriatric oncology patients.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...